Latest news
SA Asks: What's the outlook for Big Pharma M&A? (JNJ:NYSE) - Seeking AlphaSeeking Alpha · Sat, 08 Aug 2026 19:28:35 GMTPfizer: Q2 Strength Overshadows Obesity Setbacks (NYSE:PFE) - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 13:59:48 GMTTeva Pharmaceuticals: Continuing To Execute On Its ‘Pivot To Growth’ Plan (NYSE:TEVA) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 20:05:29 GMTTeva raises 2026 revenue guidance, driven by gr... - PluangPluang · Wed, 05 Aug 2026 07:00:00 GMTTeva’s Re-Rating Still Has Room To Run (NYSE:TEVA) - Seeking AlphaSeeking Alpha · Mon, 03 Aug 2026 17:32:28 GMTAbbVie: Strong Q2 And New Catalysts Keep Me Bullish (NYSE:ABBV) - Seeking AlphaSeeking Alpha · Mon, 03 Aug 2026 14:05:31 GMTTeva Pharmaceutical shifts to specialty drugs, targets $3.7B sales by 2026 and 30% margins by 2027 - PluangPluang · Mon, 03 Aug 2026 07:00:00 GMTTeva Pharmaceutical Industries Limited 2026 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) 2026-07-31 - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 23:09:47 GMT